I’m Michelle Yee. I work in Cell and Gene therapy, bringing together a background in cancer biology, hands-on manufacturing support, and global product management.
I’m driven by solving complex challenges—and bringing in the right people, or stakeholders, to deliver the solution.
Let’s connect ↓My path has taken me from research and teaching in Singapore to technical support and global product management at Miltenyi Biotec.
Each role adds a different perspective: investigating mechanisms, explaining complex ideas, understanding customer challenges, and translating those insights into product decisions.
Global marketing and commercial promotion of off-the-shelf T cell manufacturing workflows for CAR T and TCR applications. Partnering with R&D on applications and bringing customer and market insights into positioning and priorities.
Supported clinical cell manufacturing runs and flow cytometry analytics as part of a global team. Hands-on troubleshooting, technical transfer, and international customer and field team training grounded my understanding of manufacturing challenges.
Conducted collaborative research, mentored students, and designed and taught a course on biomedicine in Singapore society.
My PhD in Cancer Biology investigated how cellular redox changes can influence signalling associated with inflammation and carcinogenesis in breast cancer and osteosarcoma.
I chose to pursue a diploma in Molecular Biotechnology for its hands-on, practical approach, then continued with a bachelor’s degree and PhD at NUS. Learning by doing remains central to how I approach new challenges.
Taking on a new role in Germany, I draw on my technical experience and product expertise in product management and marketing.
View my backgroundFour years on the other side of the support line changed what I bring to product.
In clinical cell manufacturing, an instrument or application issue can put a batch at risk, and behind that batch is a patient waiting for therapy.
I became a technical partner to teams in GMP manufacturing. I trained more than 100 clinical application specialists and customers in person, at their sites and at training centres, so they could run the manufacturing workflow themselves, and I coached six trainers across Asia and Europe. I also resolved time-critical problems so a manufacturing batch would not fail.
I’m currently based in Cologne, working as a Global Product Manager in Immunotherapy at Miltenyi Biotec.
I oversee global strategy and commercialisation for engineered T cell manufacturing workflows for CAR T and TCR therapies.
The view is broader now. I listen to customers and clinical experts, weigh what is worth developing, and set priorities. The aim is to help scientists and cell therapy manufacturers around the world create and deliver life-changing therapies.
But I haven’t left the practical questions behind. A strategy has to hold up in the GMP suite as well as in a meeting room. I have done both, and I use that combination to take on the challenge.
For the professional detailI take a genuine interest in the challenge. I listen until I understand it, and I am driven to solve it by bringing the right people together, across disciplines.
A customer considering a new application needed information to assess comparability with their existing process. Several teams were involved, but the next step was unclear.
Through everyday conversations, I knew an R&D colleague working on the relevant topic. I proposed bringing them into the discussion so their experience could help address the customer’s questions and move the conversation forward.
Right now, that includes AI.
I’m learning how to use it thoughtfully in my work, especially where scientific insight and product decisions meet. I see it as a force multiplier: something that can help me notice and connect more than I could alone — not a substitute for scientific or commercial judgment. The work is learning where it helps, and knowing when to question it.
A new tool. The same instinct to try it for myself.
Interested in connecting about Cell and Gene therapy, manufacturing workflows, using AI in this work, or a potential opportunity to work together?